BOSULIF is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Bosutinib Monohydrate.
Product ID | 0069-0136_28ccd2f3-a7b1-44fa-8dab-cb6a88fffd27 |
NDC | 0069-0136 |
Product Type | Human Prescription Drug |
Proprietary Name | BOSULIF |
Generic Name | Bosutinib Monohydrate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2012-09-04 |
Marketing Category | NDA / NDA |
Application Number | NDA203341 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | BOSUTINIB MONOHYDRATE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-09-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA203341 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-09-04 |
Ingredient | Strength |
---|---|
BOSUTINIB MONOHYDRATE | 500 mg/1 |
SPL SET ID: | adc84ad5-a04d-4fee-9ba8-91f7abd928e3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0069-0135 | BOSULIF | Bosutinib monohydrate |
0069-0136 | BOSULIF | Bosutinib monohydrate |
0069-0193 | BOSULIF | Bosutinib monohydrate |
63539-117 | BOSULIF | Bosutinib |
63539-193 | BOSULIF | Bosutinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BOSULIF 85254857 4292873 Live/Registered |
Wyeth LLC 2011-03-01 |
BOSULIF 77813503 3971238 Live/Registered |
WYETH LLC 2009-08-26 |